Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,345 | 216 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $565.23 | 28 | $0 (2024) |
| SANOFI PASTEUR INC. | $422.15 | 19 | $0 (2024) |
| Novo Nordisk Inc | $395.98 | 20 | $0 (2024) |
| Lilly USA, LLC | $367.88 | 17 | $0 (2024) |
| Bausch Health US, LLC | $344.59 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $292.05 | 12 | $0 (2024) |
| Abbott Laboratories | $267.56 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $258.78 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $206.41 | 12 | $0 (2024) |
| Amgen Inc. | $133.80 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $955.45 | 43 | Lilly USA, LLC ($169.25) |
| 2023 | $1,024 | 48 | AbbVie Inc. ($132.01) |
| 2022 | $743.74 | 35 | ABBVIE INC. ($177.39) |
| 2021 | $300.17 | 14 | AbbVie Inc. ($62.09) |
| 2020 | $370.46 | 20 | Bausch Health US, LLC ($102.01) |
| 2019 | $402.60 | 24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($109.22) |
| 2018 | $333.33 | 20 | Sanofi Pasteur Inc. ($79.39) |
| 2017 | $215.20 | 12 | AbbVie, Inc. ($58.22) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Diabetes Care | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: VACCINE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes Care | ||||||
| 09/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes Care | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: VACCINE | ||||||
| 07/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: VACCINES | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Diabetes | ||||||
| 07/03/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 355 | 581 | $40,524 | $29,037 |
| 2022 | 8 | 266 | 377 | $29,850 | $21,236 |
| 2021 | 7 | 255 | 348 | $28,944 | $21,400 |
| 2020 | 5 | 199 | 263 | $19,338 | $12,518 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $8,113 | $7,951 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 145 | $12,035 | $7,673 | 63.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 42 | $5,166 | $3,409 | 66.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 64 | $3,840 | $2,557 | 66.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 36 | $2,880 | $1,835 | 63.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 33 | $2,145 | $1,457 | 67.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 58 | 58 | $1,740 | $1,139 | 65.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 15 | $1,134 | $1,076 | 94.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 15 | 27 | $1,296 | $873.99 | 67.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 15 | $440.00 | $431.20 | 98.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 22 | 22 | $550.00 | $351.57 | 63.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 15 | 51 | $765.00 | $163.71 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $420.00 | $120.20 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 143 | $11,869 | $6,833 | 57.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $6,916 | $6,811 | 98.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 55 | $6,765 | $4,131 | 61.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $2,100 | $2,053 | 97.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 32 | $860.00 | $843.20 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $305.00 | $300.15 | 98.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 17 | 41 | $615.00 | $132.57 | 21.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $420.00 | $131.81 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 57 | 57 | $7,581 | $7,581 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 127 | $10,541 | $5,908 | 56.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 59 | $7,257 | $5,163 | 71.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 28 | 29 | $2,020 | $1,884 | 93.3% |
About Dr. Elana Sheldon, MD
Dr. Elana Sheldon, MD is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790708915.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elana Sheldon, MD has received a total of $4,345 in payments from pharmaceutical and medical device companies, with $955.45 received in 2024. These payments were reported across 216 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,345).
As a Medicare-enrolled provider, Sheldon has provided services to 1,075 Medicare beneficiaries, totaling 1,569 services with total Medicare billing of $84,191. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pasadena, CA
- Active Since 07/26/2006
- Last Updated 02/27/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790708915
Products in Payments
- MOUNJARO (Drug) $251.09
- APLENZIN (Drug) $242.36
- XIFAXAN (Drug) $238.86
- QULIPTA (Drug) $197.18
- UBRELVY (Drug) $177.16
- NURTEC ODT (Drug) $170.45
- FREESTYLE LIBRE 3 (Device) $139.03
- FREESTYLE LIBRE 2 (Device) $128.53
- FLUZONE HIGH-DOSE (Drug) $124.24
- Wegovy (Drug) $122.55
- Ozempic (Drug) $121.61
- JARDIANCE (Drug) $120.61
- SHINGRIX (Biological) $107.61
- Synthroid (Drug) $104.76
- TRELEGY ELLIPTA (Drug) $104.15
- WELLBUTRIN (Drug) $102.23
- Cologuard Collection Kit (Device) $99.82
- BREZTRI (Drug) $94.28
- Otezla (Drug) $85.26
- Rybelsus (Drug) $80.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882